![](/img/cover-not-exists.png)
What is Germany's experience on reference based drug pricing and the etiology of adverse health outcomes or substitution?
Sebastian Schneeweiss, Oliver Schöffski, Gisbert W SelkeVolume:
44
Year:
1998
Language:
english
DOI:
10.1016/s0168-8510(98)00023-2
File:
PDF, 71 KB
english, 1998